The story of sickle cell disease in Michigan has always been one of resilience. Black families have advocated, organized, and cared for each other when systems looked the other way. This program has ...

Despite making significant clinical progress, CRISPR Therapeutics (NASDAQ: CRSP) has been struggling financially in the past ...